Lotilaner FDA approval date

The FDA approved Lotilaner (S-Misoxam) on 24 Jul 2023.

FDA approval date
24 Jul 2023

Drug identity checked against registry records

Also recorded as S-Misoxam; TP-03

Included trials

TrialSponsorPhaseStatusPrimary completion
Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA StudyNCT05629390LianBio LLCPhase 3Completed2023-09-15Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-07-24DayLotilanerFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217603", "applicant_as_listed_by_fda": "TARSUS", "brand_names": ["XDEMVY"], "active_ingredients": ["LOTILANER"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230724", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026